Baseline Characteristics
HFpEF
TYPE 2 DIABETES
A summary of the baseline characteristics of patients randomized to treatment is presented in Table 
Baseline Characteristics of the Randomized Participants
The mean duration of exposure to treatment was 85.3 days (SD, 2.4) for the empagliflozin group (n=35) and 84.55 days (SD, 3.11) for the placebo group (n=36).Overall, 58.3% of patients were men, nearly all were White (97.2%), 1.4% were Black, 1.4% were of Asian ancestry, and the mean age was 68.33 years (SD, 11.51). In the HFrEF cohort, all patients had an LVEF ≤40% before treatment. The mean eGFR was 73.6 mL/(min/1.73 mIn the HFpEF cohort, all patients had an LVEF of ≥50%. Mean eGFR was 72.0 mL/(min/1.73 mIt was anticipated that patients with type 2 diabetes would account for 30% to 40% of those randomized; however, only 12.55% of all patients enrolled eventually had concomitant type 2 diabetes.